You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 214136

✉ Email this page to a colleague

« Back to Dashboard

NDA 214136 describes TAZAROTENE, which is a drug marketed by Cosette, Fougera Pharms Inc, Padagis Israel, Sun Pharma Canada, and Solaris Pharma Corp, and is included in nine NDAs. It is available from six suppliers. Additional details are available on the TAZAROTENE profile page.

The generic ingredient in TAZAROTENE is tazarotene. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tazarotene profile page.

Summary for 214136

Tradename:	TAZAROTENE
Applicant:	Cosette
Ingredient:	tazarotene
Patents:	0

Pharmacology for NDA: 214136

Suppliers and Packaging for NDA: 214136

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TAZAROTENE	tazarotene	GEL;TOPICAL	214136	ANDA	Cosette Pharmaceuticals, Inc.	0713-0804	0713-0804-31	1 TUBE in 1 CARTON (0713-0804-31) / 30 g in 1 TUBE
TAZAROTENE	tazarotene	GEL;TOPICAL	214136	ANDA	Cosette Pharmaceuticals, Inc.	0713-0804	0713-0804-99	1 TUBE in 1 CARTON (0713-0804-99) / 100 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	0.1%
Approval Date:	Sep 13, 2022	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.